Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Premal Lulla

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Blood|October 17, 2024
"Lymphorepletion" by IL-15Jonathan Lockhart, Premal Lulla
Human Vaccines & Immunotherapeutics|May 4, 2021
Myelodysplastic syndrome and immunotherapy novel to next in-line treatmentsKatherine Linder, Premal Lulla
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 28, 2017
Expanding Accessibility to CD19-CAR T Cells: Commercializing a "Boutique" TherapyPremal Lulla, Carlos A Ramos
Hematology. American Society of Hematology. Education Program|December 4, 2016
Checkpoint inhibition and cellular immunotherapy in lymphomaPremal Lulla, Helen E Heslop
Blood|February 4, 2017
Fall of the mutants: T cells targeting BCR-ABLPremal Lulla, Helen E Heslop
Clinical Lymphoma, Myeloma & Leukemia|November 1, 2011
Fatal paraneoplastic systemic leukocytoclastic vasculitis as a presenting feature of chronic lymphocytic leukemiaPremal Lulla, Salman Bandeali, Kelty Baker
Advances in Cell and Gene Therapy|November 29, 2019
CAR-T cell Therapy for Non-Hodgkin Lymphomas: A New Treatment ParadigmLaQuisa Hill, Premal Lulla, Helen E Heslop
Blood|December 27, 2022
Banking on virus-specific T cells to fulfill the need for off-the-shelf cell therapiesDavid H Quach, Premal Lulla, Cliona M Rooney
International Journal of Clinical Oncology|October 15, 2013
Retrospective review of extra-pulmonary small cell carcinoma and prognostic factorsJonathan Edward Brammer, Premal Lulla, Garrett Rushing Lynch
International Journal of Clinical Oncology|February 25, 2011
Complete remission in a patient with metastatic mixed adenocarcinoma/extrapulmonary small cell carcinoma of the prostateJonathan Edward Brammer, Premal Lulla, Garrett Rush Lynch
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Blood|October 17, 2024
"Lymphorepletion" by IL-15Jonathan Lockhart, Premal Lulla
Human Vaccines & Immunotherapeutics|May 4, 2021
Myelodysplastic syndrome and immunotherapy novel to next in-line treatmentsKatherine Linder, Premal Lulla
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 28, 2017
Expanding Accessibility to CD19-CAR T Cells: Commercializing a "Boutique" TherapyPremal Lulla, Carlos A Ramos
Hematology. American Society of Hematology. Education Program|December 4, 2016
Checkpoint inhibition and cellular immunotherapy in lymphomaPremal Lulla, Helen E Heslop
Blood|February 4, 2017
Fall of the mutants: T cells targeting BCR-ABLPremal Lulla, Helen E Heslop
Clinical Lymphoma, Myeloma & Leukemia|November 1, 2011
Fatal paraneoplastic systemic leukocytoclastic vasculitis as a presenting feature of chronic lymphocytic leukemiaPremal Lulla, Salman Bandeali, Kelty Baker
Advances in Cell and Gene Therapy|November 29, 2019
CAR-T cell Therapy for Non-Hodgkin Lymphomas: A New Treatment ParadigmLaQuisa Hill, Premal Lulla, Helen E Heslop
Blood|December 27, 2022
Banking on virus-specific T cells to fulfill the need for off-the-shelf cell therapiesDavid H Quach, Premal Lulla, Cliona M Rooney
International Journal of Clinical Oncology|October 15, 2013
Retrospective review of extra-pulmonary small cell carcinoma and prognostic factorsJonathan Edward Brammer, Premal Lulla, Garrett Rushing Lynch
International Journal of Clinical Oncology|February 25, 2011
Complete remission in a patient with metastatic mixed adenocarcinoma/extrapulmonary small cell carcinoma of the prostateJonathan Edward Brammer, Premal Lulla, Garrett Rush Lynch
Pageof 4